When incorporating CEA and CA199, the sensitivity of the performance of the classifier was marginally improved, suggesting that the selected gene panel possesses the CEA/CA199 comparable or even higher power in identifying CRC patients. The gene discussed is CEACAM5; the disease is colorectal carcinoma.